NewLimit

NewLimit

Medicines for healthspan extension via epigenetics

About

NewLimit develops medicines aimed at extending human healthspan by reprogramming aging cells' epigenomes. This involves changing the chemical modifications on DNA and histone proteins to restore youthful functions in old cells, focusing on diseases related to aging, particularly in the immune system and liver. The company utilizes advanced technologies like single-cell genomics, machine learning, and high-throughput functional assays to identify aging markers and create interventions that reverse these changes. Unlike competitors, NewLimit's approach is centered on epigenetic reprogramming, which could lead to a new class of medicines for age-related conditions. The goal is to significantly increase the duration of life spent in good health, serving the healthcare market, including pharmaceutical companies and individual consumers seeking anti-aging solutions.

Company Stage

Series A

Employees

11-50

Industries

Biotechnology, Healthcare

Total Funding

$38.9M

Headquarters

South San Francisco, California

Founded

2022


Simplify Jobs

Simplify's Take

What believers are saying

  • Recent $40M funding boosts NewLimit's research and development capabilities.
  • Advancements in single-cell genomics enhance NewLimit's ability to identify epigenetic markers.
  • FDA's favorable stance on aging-related therapies supports NewLimit's regulatory strategy.

What critics are saying

  • Rapid biotech advancements could render NewLimit's technologies obsolete without continuous innovation.
  • Ethical debates on cell manipulation may lead to public backlash or regulatory challenges.
  • Competitors like Altos Labs receiving significant funding could outpace NewLimit in R&D.

What makes NewLimit unique

  • NewLimit focuses on epigenetic reprogramming to extend human healthspan, a unique approach.
  • The company leverages single-cell genomics and machine learning for precise therapy development.
  • NewLimit targets rejuvenating the immune system and liver, addressing large unmet medical needs.

Help us improve and share your feedback! Did you find this helpful?


Growth & Insights
Headcount

6 month growth

22%

1 year growth

50%

2 year growth

94%

Recently Posted Jobs

Sign up to get curated job recommendations

NewLimit is Hiring for 0 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update NewLimit's jobs every 8 hours, so check again soon! Browse all jobs →